The 11th National Conference on Chinese society of osteoporosis and bone mineral research held in Hangzhou from October 28th - 30th, 2020. The conference attracted experts and scholars from all over the country to discuss the hot issues of osteoporosis, bone mineral diseases and metabolic bone diseases in China. At the meeting, Professor Huazhu Ke, CEO of Angitaibio shared the latest content of sclerostatin inhibitors. The following link is the report of CSOBMR conference:
